Sulazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401551This classification denotes an anxiolytic with the molecular formula C16H13ClN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NZ779Q5S0W, chemically known as 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1,4-benzodiazepine-2-thione but generally known as sulazepam, which bears US NIH Compound Identifier 17931. European Medicines Agency schedules Sulazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10674MIG. The term SULAZEPAM is an International Non-Proprietary Name. SULAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulazepam under HS 29339940 and SITC 51577. As of Q4 2014, SULAZEPAM remains the US FDA Preferred Term for this commodity. Sulazepam bears US NLM identifiers UMLS ID C2348591 and NCI Concept Code C73210. SMILES: CLC1CC2C(N(C(=S)CN=C2C2CCCCC2)C)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.